Gufic Biosciences Limited — Others, 30-05-2025: Change in Auditors

Gufic Biosciences has announced a board meeting on the financial results for the quarter and half-year, reporting consolidated total income of ₹823.42 Cr and net profit of ₹69.93 Cr, down from ₹86.14 Cr year-on-year. The Board proposed a final dividend of Re. 0.10 per share. Cost auditors M/s. Poddar & Co. were appointed for FY25, and M/s. Manish Ghia & Associates as secretarial auditors for five years starting FY26. The company accepted a right issue subscription in its subsidiary and plans equity investments up to ₹1 Cr each in its wholly owned offshore subsidiaries, which are yet to commence operations, reflecting strategic expansion and strong governance.